DAPAGLIFLOZIN: NEWER MOLECULE FOR TREATMENT OF TYPE 2 DIABETES MELLITUSType 2 diabetes mellitus is a common chronic disease that causes significant morbidity and mortality worldwide. Diabetes results from a combination of increased hepatic glucose product. International Research Journal of Pharmacy, [S. l.], v. 2, n. 1, p. 32–40, 2024. Disponível em: https://irjponline.org/index.php/irjp/article/view/1741. Acesso em: 24 aug. 2026.